High-sensitivity troponin I (hs-cTnI) is a blood test used to detect and measure troponin levels, a protein released when heart muscle is damaged, aiding in the early diagnosis of heart-related conditions and guiding timely medical intervention.
Here’s a more detailed explanation:
What is High-Sensitivity Troponin I?
A Sensitive Biomarker:
High-sensitivity troponin I (hs-cTnI) assays are designed to detect even very small amounts of troponin in the blood, making them more sensitive than older troponin tests.
Heart Muscle Damage:
Troponin is a protein found in heart muscle cells. When these cells are damaged, troponin is released into the bloodstream.
Early Diagnosis:
The ability of hs-cTnI assays to detect low levels of troponin allows for earlier and more accurate diagnosis of heart conditions, including heart attacks (myocardial infarction).
Clinical Applications:
Suspected Acute Coronary Syndrome:hs-cTnI is used to help diagnose and manage patients with suspected acute coronary syndrome (ACS), which includes heart attacks and unstable angina.
Cardiovascular Risk Stratification:hs-cTnI can also be used to assess cardiovascular risk in individuals, even those without apparent symptoms.
Monitoring Therapeutic Responses:hs-cTnI can be used to monitor the effectiveness of treatments for heart conditions.
How it Works:
Serial Sampling:Measuring troponin levels at multiple time points (serial sampling) is crucial to detect the characteristic rise and fall of troponin levels associated with a heart attack.
Distinguishing AMI from other conditions:Serial sampling helps differentiate a heart attack (AMI) from other conditions that can cause elevated troponin levels, such as renal failure, arrhythmias, or pulmonary embolism.
Advantages of High-Sensitivity Assays:
Increased Sensitivity:hs-cTnI assays are significantly more sensitive than older assays, allowing for earlier and more accurate detection of heart damage.
Earlier Rule-Out:They can help rule out non-ST-elevation myocardial infarction (NSTEMI) at an earlier time after the onset of chest pain.
Facilitate Earlier Discharge:In some cases, they can help facilitate earlier discharge for patients with normal troponin levels.
Important Considerations:
Not a Definitive Diagnosis:
Elevated hs-cTnI levels alone do not always indicate a heart attack, and other conditions can also cause elevated levels.
Clinical Context:
Troponin values must be interpreted in the context of the patient’s clinical presentation and other diagnostic tests.
Prompt Medical Evaluation:
Elevated hs-cTnI levels require prompt medical evaluation and treatment to prevent complications and protect heart health.
₹1,000.00Original price was: ₹1,000.00.₹500.00Current price is: ₹500.00.
Human Leukocyte antigen B27 (HLA- B27) belongs to a group of cell surface glycoproteins which are expressed on most nucleated human cells and platelets. It is a major histocompatibility complex (MHC) class I molecule. The presence of HLA – B27 is strongly associated with ankylosing spondylitis and some inflammatory disorders like Reiter’s syndrome, inflammatory bowel syndrome, etc. The binding ability of specific monoclonal antibodies to the antigenic determinants expressed by leucocytes on the surface forms the basis of this test. HLA-B 27 test is generally advised in patients suffering from joint pain where the diagnosis of ankylosing spondylitis is suspected. A positive test result indicates higher chances of developing this disease. Avail of the service by booking the HLA-B27 test online at an affordable rate, at your doorstep.
HLA-B27 is a protein found on white blood cells that helps the immune system identify harmful substances. It’s also the name of a blood test that checks for the presence of this protein.
What is HLA-B27 associated with?
Ankylosing spondylitis: An autoimmune disease that affects the spine. Most people with ankylosing spondylitis have the HLA-B27 gene, but many people with the gene never develop the disease.
Reactive arthritis: An autoimmune disease that affects the joints. 60–85% of patients with reactive arthritis are HLA-B27 positive.
Juvenile arthritis: An autoimmune disease that occurs in children.
How is the test performed?
The HLA-B27 test is a blood draw that’s usually taken from the arm.
A healthcare provider in a doctor’s office or a clinical lab administers the test.
The blood is collected in a tube and sent to a lab for analysis.
HLA-B27 prevalence
The prevalence of HLA-B27 varies between populations.
In the UK, HLA-B27 is present in 90–95% of patients with ankylosing spondylitis.
In the general population, 8 in every 100 people have the HLA-B27 gene variant.
₹2,299.00Original price was: ₹2,299.00.₹2,200.00Current price is: ₹2,200.00.
